Pelosi G, Bracchi G, Orazio S, Cereda A
Minerva Med. 1981 Feb 18;72(4-5):225-31.
0.3 mg/day betamethyldigoxin was given per os in three daily administrations to 8 healthy subjects, and 8 compensated and 8 decompensated heart patients. Prior to the treatment, and 6 hr after the last administration, blood digoxin values were determined radio-immunologically, together with cardiac output, systolic stroke volume, cardiac index (dilution of indocyanine green), and systolic time intervals, by simultaneous recording of the ECG, carotid pulse, and the phonocardiogram. No significant change in output, stroke volume and cardiac index was noted in the healthy subjects, whereas these parameters were distinctly improved in the decompensated patients. Changes in the systolic intervals after treatment were significant in all cases though there was no significant correlation with the blood digoxin levels reached. In particular, the healthy and compensated subjects displayed a reduction in the corrected electromechanical systole (delta Q-S2), the corrected pre-ejection period (delta PEP), the corrected left ventricular ejection time (delta LVET), and their ratio (PEP/LVET), whereas in the decompensated patients the picture differed to the extent that the LVET increased owing to an augment-systolic stroke volume, the other parameters being reduced. In the healthy subjects, the polygraphic data were normal prior to the treatment, while in the compensated patients delta PEP and the PEP/LVET ratio were enhanced, and the delta LVET was less than in the normal subjects. It is felt that recording of the systolic intervals may be regarded as a sound method, owing to its simplicity and its ability to demonstrate latent cardiac failure before haemodynamic changes appear. Simultaneous determination of serum digoxin and the polygraphic data, therefore, opens the way to the commencement of appropriate, safe and timely management of as yet non-decompensated heart patients.
对8名健康受试者、8名代偿性心脏病患者和8名失代偿性心脏病患者,每日分三次口服给予0.3毫克/天的倍他米松地高辛。在治疗前以及最后一次给药后6小时,通过同步记录心电图、颈动脉搏动和心音图,采用放射免疫法测定血液地高辛值,同时测定心输出量、收缩期搏出量、心脏指数(吲哚菁绿稀释法)和收缩期时间间期。健康受试者的心输出量、搏出量和心脏指数无显著变化,而失代偿患者的这些参数明显改善。治疗后收缩期时间间期的变化在所有病例中均有显著意义,尽管与达到的血液地高辛水平无显著相关性。特别是,健康受试者和代偿性患者的校正机电收缩期(δQ-S2)、校正射血前期(δPEP)、校正左心室射血时间(δLVET)及其比值(PEP/LVET)均降低,而失代偿患者的情况有所不同,由于收缩期搏出量增加,LVET增加,其他参数降低。在健康受试者中,治疗前多导记录数据正常,而在代偿性患者中,δPEP和PEP/LVET比值升高,δLVET低于正常受试者。由于其简单性以及能够在血流动力学变化出现之前显示潜在心力衰竭的能力,收缩期时间间期的记录可被视为一种可靠的方法。因此,同时测定血清地高辛和多导记录数据为尚未失代偿的心脏病患者开始适当、安全和及时的治疗开辟了道路。